Spots Global Cancer Trial Database for hyperandrogenism
Every month we try and update this database with for hyperandrogenism cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women | NCT01889199 | Polycystic Ovar... | Flutamide Placebo | 18 Years - 35 Years | University of California, Los Angeles | |
| Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients | NCT05555680 | PCOS (Polycysti... | Ferriman-Gallwe... | 18 Years - 39 Years | Clinique Ovo | |
| Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone | NCT01428089 | Polycystic Ovar... Hyperandrogenis... Normal Puberty | Progesterone Placebo | 7 Years - 14 Years | University of Virginia | |
| Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome | NCT00665171 | Anovulation Hyperandrogenis... Polycystic Ovar... Single Nucleoti... | - | Maaynei Hayesha Medical Center | ||
| Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients | NCT05555680 | PCOS (Polycysti... | Ferriman-Gallwe... | 18 Years - 39 Years | Clinique Ovo | |
| Continuous Versus Cyclical OCP Use in PCOS | NCT03819140 | Polycystic Ovar... | Yasmin | 15 Years - 40 Years | University of California, San Francisco | |
| Phenotype and Epidemiology of the Polycystic Ovary Syndrome (PCOS) in Colombia (PEP - Colombia) Study. | NCT05926115 | Polycystic Ovar... Hyperandrogenis... Endocrine Syste... | Diagnostic Ultr... Venous puncture | 18 Years - 45 Years | Instituto de fertilidad humana, InSer | |
| Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance | NCT01511822 | PCOS Polycystic Ovar... | Drospirenone Et... Drospirenone Et... placebo | 18 Years - 35 Years | AGUNCO Obstetrics and Gynecology Centre | |
| Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome | NCT01569425 | Hyperandrogenis... Insulin Resista... | Dietary interve... | 18 Years - 45 Years | Tel Aviv University | |
| Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS) | NCT02052479 | Polycystic Ovar... PCOS | Frequently Samp... | 12 Years - 18 Years | Nationwide Children's Hospital | |
| Metabolic and Endocrine Status in Women With Prior Preterm Birth | NCT01355536 | Polycystic Ovar... Preterm Birth Diabetes Mellit... | - | Namsos Hospital | ||
| Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone | NCT01428193 | Polycystic Ovar... Hyperandrogenis... | Flutamide Progesterone estrace | 13 Years - 17 Years | University of Virginia | |
| Use of Osteopathic Principles for Nonpharmacologic, Therapeutic Interventions in Women With Polycystic Ovary Syndrome | NCT03383484 | Polycystic Ovar... | OMT Yoga | 20 Years - 44 Years | Lake Erie College of Osteopathic Medicine | |
| Continuous Versus Cyclical OCP Use in PCOS | NCT03819140 | Polycystic Ovar... | Yasmin | 15 Years - 40 Years | University of California, San Francisco | |
| Phenotype and Epidemiology of the Polycystic Ovary Syndrome (PCOS) in Colombia (PEP - Colombia) Study. | NCT05926115 | Polycystic Ovar... Hyperandrogenis... Endocrine Syste... | Diagnostic Ultr... Venous puncture | 18 Years - 45 Years | Instituto de fertilidad humana, InSer | |
| Lactobacillus Rhamnosus and PCOS Treatment | NCT03902301 | Insulin Resista... Polycystic Ovar... Hyperandrogenis... Obesity | Lactobacillus g... Dietary group | 18 Years - 40 Years | Poznan University of Life Sciences | |
| Effects of Metformin and Oral Hormonal Contraceptive in Adolescents With Polycystic Ovary Syndrome | NCT00988078 | Polycystic Ovar... | Placebo Metformin | 11 Years - 19 Years | Federal University of São Paulo | |
| Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome | NCT03088046 | Anovulation Polycystic Ovar... Hyperandrogenis... | Micronized Prog... | 18 Years - 35 Years | Institut Universitari Dexeus | |
| The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women | NCT00413179 | Polycystic Ovar... Anovulation Oligoovulation Infertility Hyperandrogenis... | Metformin Clomiphene citr... Placebo | 18 Years - 40 Years | 59th Medical Wing | |
| Metabolic and Endocrine Status in Women With Prior Preterm Birth | NCT01355536 | Polycystic Ovar... Preterm Birth Diabetes Mellit... | - | Namsos Hospital | ||
| Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS) | NCT02052479 | Polycystic Ovar... PCOS | Frequently Samp... | 12 Years - 18 Years | Nationwide Children's Hospital | |
| Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome | NCT01475565 | Polycystic Ovar... Insulin Resista... Insulin Sensiti... Obesity Pregnancy | 18 Years - 40 Years | Virginia Commonwealth University | ||
| Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism? | NCT04723862 | Hyperandrogenis... Polycystic Ovar... Puberty | Spironolactone Placebo | 10 Years - 17 Years | University of Virginia | |
| Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism? | NCT04723862 | Hyperandrogenis... Polycystic Ovar... Puberty | Spironolactone Placebo | 10 Years - 17 Years | University of Virginia | |
| Acupuncture or Metformin for Insulin Resistance in Women With PCOS | NCT02647827 | Polycystic Ovar... Insulin Resista... Hyperandrogenis... | Lifestyle manag... Acupuncture Metformin | 18 Years - 40 Years | Karolinska Institutet | |
| Body Fat as Determinant of Female Gonadal Dysfunction | NCT03841981 | Polycystic Ovar... Hypothalamic Am... | Anthropometric ... Indirect calori... Biochemical, ho... Sonographic stu... 24-hour Ambulat... Percutaneous bi... Cardiovascular ... Oral smear and ... | 18 Years - 40 Years | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | |
| Phlebotomy and Polycystic Ovary Syndrome | NCT02460445 | Hyperandrogenis... Metabolic Cardi... | Phlebotomy ethinylestradio... Cyproterone Ace... | 18 Years - 45 Years | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | |
| Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study | NCT03742011 | PCOS Offspring, Adul... Hyperandrogenis... Epigenetics Insulin Resista... Endocrine Disor... Metabolic Distu... | - 18 Years | Guangzhou Women and Children's Medical Center | ||
| Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome | NCT03088046 | Anovulation Polycystic Ovar... Hyperandrogenis... | Micronized Prog... | 18 Years - 35 Years | Institut Universitari Dexeus | |
| Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance | NCT01511822 | PCOS Polycystic Ovar... | Drospirenone Et... Drospirenone Et... placebo | 18 Years - 35 Years | AGUNCO Obstetrics and Gynecology Centre | |
| International Registry of Congenital Portosystemic Shunt (IRCPSS) | NCT06041906 | Congenital Port... | Shunt Closure | 1 Day - | University Hospital, Geneva | |
| Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome | NCT03088046 | Anovulation Polycystic Ovar... Hyperandrogenis... | Micronized Prog... | 18 Years - 35 Years | Institut Universitari Dexeus | |
| PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2 | NCT00444288 | Polycystic Ovar... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS | NCT03252223 | Polycystic Ovar... Healthy Anovulation Hyperandrogenis... | Recombinant Fol... | 18 Years - 37 Years | University of California, San Diego | |
| Inositol Supplementation to Treat PCOS (INSUPP-PCOS) | NCT03864068 | Polycystic Ovar... Anovulation Hyperandrogenis... Insulin Resista... Glucose Intoler... Metabolic Compl... | Placebo Inositol | 18 Years - 45 Years | Milton S. Hershey Medical Center | |
| Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women | NCT02651636 | Polycystic Ovar... Menstrual Patte... Hyperandrogenis... Metabolic Featu... | myo-inositol,al... | 18 Years - 35 Years | Catholic University of the Sacred Heart | |
| Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors | NCT00317928 | Polycystic Ovar... | Metformin | 20 Years - 45 Years | Aarhus University Hospital Skejby | |
| Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome | NCT01569425 | Hyperandrogenis... Insulin Resista... | Dietary interve... | 18 Years - 45 Years | Tel Aviv University | |
| Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction | NCT03229408 | Polycystic Ovar... | Salsalate Placebo | 18 Years - 40 Years | University of Illinois at Chicago | |
| Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome | NCT04453306 | Obesity Polycystic Ovar... Hyperandrogenis... | Topiramate Placebo | 18 Years - 40 Years | Hospital de Clinicas de Porto Alegre | |
| Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS | NCT00428311 | Polycystic Ovar... | Metformin Ethynyl-estradi... | 12 Years - 45 Years | Hospital Universitario Ramon y Cajal | |
| Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women | NCT04006171 | Polycystic Ovar... c Type Natriure... Menstrual Irreg... Hyperandrogenis... | C type natriure... | 18 Years - 40 Years | Near East University, Turkey | |
| Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors | NCT00317928 | Polycystic Ovar... | Metformin | 20 Years - 45 Years | Aarhus University Hospital Skejby | |
| Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone | NCT01428089 | Polycystic Ovar... Hyperandrogenis... Normal Puberty | Progesterone Placebo | 7 Years - 14 Years | University of Virginia | |
| Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant | NCT02523898 | Polycystic Ovar... Hyperandrogenis... | metformine placebo clomiphene citr... | 20 Years - 36 Years | Semnan University of Medical Sciences | |
| Myo-inositol, Alpha-Lactalbumin and Folic Acid Treatment in PCOS | NCT04645745 | Polycystic Ovar... | myo-inositol, a... | 18 Years - 40 Years | AGUNCO Obstetrics and Gynecology Centre | |
| Lactobacillus Rhamnosus and PCOS Treatment | NCT03902301 | Insulin Resista... Polycystic Ovar... Hyperandrogenis... Obesity | Lactobacillus g... Dietary group | 18 Years - 40 Years | Poznan University of Life Sciences | |
| Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women | NCT04006171 | Polycystic Ovar... c Type Natriure... Menstrual Irreg... Hyperandrogenis... | C type natriure... | 18 Years - 40 Years | Near East University, Turkey | |
| Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome | NCT00665171 | Anovulation Hyperandrogenis... Polycystic Ovar... Single Nucleoti... | - | Maaynei Hayesha Medical Center | ||
| Use of Osteopathic Principles for Nonpharmacologic, Therapeutic Interventions in Women With Polycystic Ovary Syndrome | NCT03383484 | Polycystic Ovar... | OMT Yoga | 20 Years - 44 Years | Lake Erie College of Osteopathic Medicine | |
| Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women | NCT02651636 | Polycystic Ovar... Menstrual Patte... Hyperandrogenis... Metabolic Featu... | myo-inositol,al... | 18 Years - 35 Years | Catholic University of the Sacred Heart | |
| Lactobacillus Rhamnosus and PCOS Treatment | NCT03902301 | Insulin Resista... Polycystic Ovar... Hyperandrogenis... Obesity | Lactobacillus g... Dietary group | 18 Years - 40 Years | Poznan University of Life Sciences | |
| Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome | NCT04453306 | Obesity Polycystic Ovar... Hyperandrogenis... | Topiramate Placebo | 18 Years - 40 Years | Hospital de Clinicas de Porto Alegre | |
| Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS) | NCT01489319 | Polycystic Ovar... | Salsalate Salsalate | 18 Years - 40 Years | Indiana University | |
| Androgen Metabolism and Reproductive Outcome | NCT02106676 | Polycystic Ovar... Healthy Pregnan... | 18 Years - 45 Years | Medical University of Graz | ||
| International Registry of Congenital Portosystemic Shunt (IRCPSS) | NCT06041906 | Congenital Port... | Shunt Closure | 1 Day - | University Hospital, Geneva | |
| Continuous Versus Cyclical OCP Use in PCOS | NCT03819140 | Polycystic Ovar... | Yasmin | 15 Years - 40 Years | University of California, San Francisco |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
